Medical Director, Clinical Development, Hematology Oncology

• Lead clinical strategy and deliverables for an assigned section of a clinical program


• Drive execution across trial phases in partnership with global line functions


• Guide and support assigned Clinical Scientists and Clinical Operations associates


• Represent the program in interactions with regulatory authorities, key opinion leaders, and advisory boards


• Partner cross-functionally with Research, Early Clinical Development, Medical Affairs, Marketing, and HE&OR


• Contribute to internal decision boards shaping program direction


• Shape Global Clinical Development standards by authoring or reviewing SOPs


• Participate in training programs and strategic taskforces that advance clinical development practices

Requirements

• MD or equivalent medical degree with clinical Residency training


• Hematology or Oncology fellowship training strongly preferred


• More than 2 years of experience in clinical research or drug development (academic or industry), spanning Phases I through IV


• Medical/scientific expertise in the disease area of the assigned program, hematologic malignancies, preferred

Core Competencies

Demonstrates expertise in leading clinical strategy and execution across trial phases, with a strong focus on hematologic malignancies. Possesses a medical degree and extensive experience in clinical research and drug development, ensuring compliance with global clinical development standards.

Highest-signal resume keywords

• MD Or Equivalent Medical Degree


• Clinical Residency Training


• Hematology Or Oncology Fellowship Training


• Clinical Research Experience


• Medical/Scientific Expertise In Hematologic Malignancies

ATS Optimization Keywords

Hard Skills

• Clinical Strategy Development


• Trial Phase Execution


• SOP Authoring And Reviewing


• Clinical Program Representation


• Cross-Functional Collaboration

Soft Skills

• Leadership


• Guidance And Support


• Communication

Industry Keywords

• Clinical Research


• Drug Development


• Regulatory Interactions


• Key Opinion Leaders


• Advisory Boards